S-1/A: Waystar Holding Corp. Files Amendment No. 7 to Form S-1 for IPO

• Waystar Holding Corp. filed Amendment No. 7 to its Form S-1 registration statement for an IPO.
• The company is offering 45,000,000 shares of common stock.
• The expected initial public offering price is between $20.00 and $23.00 per share.
• The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol WAY.
• Underwriters have a 30-day option to purchase up to 6,750,000 additional shares.
• Neuberger Berman and Qatar Investment Authority have indicated an interest in purchasing up to $225.0 million in shares.
• The company intends to use the net proceeds from this offering to repay outstanding indebtedness under its First Lien Credit Facility.
• The company is an emerging growth company and has elected to comply with certain reduced public company reporting requirements.
• The document also includes an employment agreement for Matthew J. Hawkins, the Chief Executive Officer, detailing his compensation, duties, and termination conditions.

Score: 7

Explanation: The document is largely factual and descriptive, outlining the terms of the IPO and related agreements. While it mentions risks, the overall tone is neutral to positive, reflecting the company's growth strategies and market opportunity.

• The company is pursuing an IPO to raise capital.
• Key investors have expressed interest in purchasing a significant portion of the offered shares.
• The CEO's employment agreement is formalized, providing stability in leadership.

• The company is an emerging growth company, which means reduced disclosure requirements.
• The company has a history of net losses and may not achieve or maintain profitability.
• The document mentions potential risks related to the company's business and industry.

• The company operates in a highly competitive industry.
• The company's ability to retain existing clients and attract new ones is crucial.
• The company's growth depends on successful execution of its business strategies.
• The company faces risks related to acquisitions and integration of acquired businesses.
• The company relies on strategic relationships and channel partners.
• The company's revenues are affected by the growth and success of its clients and overall healthcare transaction volumes.
• The company is subject to consolidation in the healthcare industry.
• The company faces a variable selling cycle and an implementation cycle dependent on clients resources.
• The company depends on its senior management team and must attract and retain skilled employees.
• The company's market estimates may be inaccurate.
• The company must develop and market new solutions to respond to technological changes.
• The company's solutions must interoperate with clients' existing systems.
• The company's business depends on the performance and reliability of internet infrastructure.
• The company must be able to obtain, process, use, disclose, or distribute highly regulated data.
• The company relies on certain third-party vendors and providers.
• The company's products and solutions may contain errors or malfunctions.
• The company's clients must obtain proper permissions and provide accurate information.
• The company faces the potential for embezzlement, identity theft, or other illegal behavior by employees or vendors.
• The company must comply with NACHA rules and card network requirements.
• The company is subject to increases in card network fees.
• The company is affected by payer and provider conduct which it cannot control.
• The company faces privacy concerns and security breaches relating to its platform.
• The company is subject to complex and evolving laws regarding privacy, data protection, and cybersecurity.
• The company must adequately protect and enforce its intellectual property rights.
• The company must be able to use or license data and integrate third-party technologies.
• The company uses open source software.
• The company may face legal proceedings alleging intellectual property infringement.
• The company may be subject to claims that employees have wrongfully used confidential information.
• The company operates in a heavily regulated industry.
• The company faces an uncertain and evolving healthcare regulatory and political framework.
• The company is subject to health care laws and data privacy and security laws.
• The company may experience reduced revenues due to changes in the healthcare regulatory landscape.
• The company may be involved in legal, regulatory, and other proceedings.
• The company is subject to consumer protection laws and regulations.
• The company must comply with Bank Secrecy Act and Anti-Money Laundering laws.
• The company's marketing activities are regulated by existing laws.
• The company must fully comply with website accessibility standards.
• The company may face changes in tax rates, new tax legislation, or additional tax liabilities.
• The company's ability to use net operating losses may be limited.
• The company may incur losses due to asset impairment charges.
• The company is subject to restrictive covenants in its Credit Facilities.
• The company faces interest rate fluctuations.
• The company may not be able to obtain additional capital on acceptable terms.
• The company is impacted by general macroeconomic conditions.
• The company has a history of net losses and may not achieve or maintain profitability.
• The interests of the Institutional Investors may differ from other holders of the company's securities.
• The company's status as an emerging growth company may make its common stock less attractive to investors.

The company expects to expand its TAM further over time as it develops new solutions and addresses adjacent workflows and expects it will continue to grow its market share in the future by virtue of its differentiated platform and capabilities.

The announcement reflects the ongoing activity in the healthcare technology sector, particularly in companies focused on revenue cycle management and payment solutions. Competitors in this space include companies like R1 RCM, Optum, and Cerner, which also offer comprehensive solutions for healthcare providers. The IPO indicates investor interest in companies that can streamline healthcare payments and reduce administrative costs.

• Waystar's revenue cycle management solutions compete with those offered by companies like R1 RCM, which provides end-to-end revenue cycle services to hospitals and health systems.
• In the patient payment solutions market, Waystar competes with companies like PatientPop and InstaMed (now part of J.P. Morgan), which offer digital payment platforms for healthcare providers.
• The company's focus on AI and automation aligns with industry trends, as healthcare providers increasingly seek to leverage technology to improve efficiency and reduce costs.
• The company's Net Revenue Retention Rate of 108.8% for the twelve months ended March 31, 2024, indicates strong customer loyalty and recurring revenue, which is a key metric for SaaS companies.

• Shareholders: The IPO will provide liquidity for existing shareholders and allow new investors to participate in the company's growth.
• Employees: The equity incentive plan and employee stock purchase plan will provide employees with opportunities to acquire ownership in the company.
• Customers: The company's continued focus on innovation and customer service will benefit its healthcare provider clients.
• Suppliers: The company's financial stability and growth will provide opportunities for its suppliers.
• Creditors: The use of proceeds to repay debt will improve the company's financial position and creditworthiness.

• The company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act.
• The company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the second business day next succeeding the date of this Agreement.
• The company will use its reasonable best efforts to list for quotation the Shares on the Nasdaq Global Select Market.

• Affiliates of Bain and CPPIB are lenders under the First Lien Credit Facility.
• Canada Pension Plan Investment Board has an ownership interest in the landlord that leases the company office space in Houston, Texas.
• Bain Capital LP has an ownership interest in some clients for whom the company provides software solutions.
• Bain Capital LP has an ownership interest in a vendor that provides the company with software solutions.

• October 18, 2017: Date of the Prior Agreement between Executive and the Company or a subsidiary thereof.
• August 13, 2019: Date of original incorporation in Delaware.
• October 22, 2019: Date of the First Lien Credit Agreement.
• August 13, 2021: Date of the receivables financing agreement.
• November 2, 2023: Effective Date of the Employment Agreement.
• May 28, 2024: Date of the S-1/A filing.